2015 Sep 18
Missing the soil for the seeds in cancer research
Claudia Fischbach-Teschl, Ph.D., pens a guest post about the importance of targeting the tumor microenvironment in cancer research and therapy. Read more
2015 Sep 18
Researchers decode role of leading mutated gene in cancer
A team led by Ari Melnick, M.D., has found that a genetic mutation implicated in a common and incurable form of non-Hodgkin lymphoma drives disease development by disrupting the mechanism that manages normal immune cell growth. Read more
2015 Sep 15
Nivolumab over docetaxel for patients with NSCLC
Ashish Saxena, M.D., Ph.D., comments on a study that found nivolumab offers better outcomes than docetaxel for patients with advanced squamous-cell non-small cell lung cancer. Read more
2015 Sep 15
Active surveillance may be underused for men with localized prostate cancer
Watchful waiting or active treatment? Jim Hu, M.D., has studied surveillance strategies among patients diagnosed with localized prostate cancer. Read more
2015 Sep 10
Gift Names Caryl and Israel Englander Institute for Precision Medicine
A gift from the Englander family will expand the Institute of Precision Medicine, including additional areas of oncology such as melanoma. Read more
2015 Sep 02
Give a liver, save a life
Profile of the new chief of liver transplantation and hepatobiliary surgery, Benjamin Samstein, M.D. Read more
2015 Sep 01
Hormone replacement therapy and breast cancer risk
Tessa Cigler, M.D., writes a commentary on recent research into breast cancer risk associated with hormone replacement therapy. Read more
2015 Aug 31
The promise and roadblocks of mobile app technology
Heather Yeo, M.D., writes a guest blog post about areas where mobile technologies have the potential to benefit patients and physicians. Read more
2015 Aug 26
Noncoding RNAs: A Cache of Cancer Clues?
Studies into the role of estrogen receptors in prostate cancer by Dimple Chakravarty and colleagues are highlighted in an article about noncoding RNAs. Read more
2015 Aug 25
Already too late to stop costly radiotherapy and surgery technologies?
Jim Hu, M.D., discusses the need to assess functional and survival outcomes of robotic surgery among prostate cancer patients. Read more
2015 Aug 19
Stiffer breast tissue in obese women promotes tumors
A study by Claudia Fischbach, Andrew Dannenberg and others has found that obesity changes the consistency of breast tissue in ways that are similar to tumors, thereby promoting disease. Read more
2015 Aug 18
Gender has surprising influence on survival after pediatric brain tumor removal
A retrospective study of pediatric brain tumors by Jeffrey Greenfield, M.D., has found gender differences in survival outcomes. Read more
2015 Aug 17
Genomic profiling provides much-needed prognostic data in glioma
Howard Fine, M.D., comments on attempts by researchers and clinicians to better classify low-grade gliomas. Read more
2015 Aug 13
Oxaliplatin pre-, post-surgery extends DFS for patients with advanced rectal cancer
Heather Yeo, M.D., comments on a study about a combination treatment option for patients with locally advanced rectal cancer. Read more
2015 Aug 10
Leaders in cancer research and clinical care
The Meyer Cancer Center is featured in a set of invited commentaries in Clinical Oncology News. Read more
2015 Aug 04
$1m grant to support genomic study of prostate cancer progression
Mark Rubin, M.D., will lead an investigation into the genomics of prostate cancer progression. Read more
2015 Jul 28
Breathing new life into lung cancer research
Thoracic surgeon Brendon Stiles is slicing away at the science behind lung cancer metastasis. Read more
2015 Jul 23
End-of-Life chemotherapy may do more harm than good
Treating terminally ill cancer patients with chemotherapy in the months or weeks before their deaths was not found to improve patients' quality of life and may actually do more harm than good, according to a new study led by Holly Prigerson, Ph.D. Read more
2015 Jul 16
Karla Ballman named chief of biostatistics and epidemiology
Renowned biostatistician Karla Ballman, Ph.D., has been named chief of the Division of Biostatics and Epidemiology in the Department of Healthcare Policy and Research at Weill Cornell Medical College. Read more
2015 Jul 14
Immune cells recruited to support lung cancer growth
Lung cancers attract circulating immune cells to the tumor mass, where the cancer reprograms them to support its growth and progression, according to a study by Vivek Mittal and colleagues. Read more
